Table of Contents
- 1 What are some recent breakthroughs in cancer research?
- 2 What innovations are helping the fight against lung cancer?
- 3 When was the first cancer treatment made?
- 4 How has technology helped cancer research?
- 5 What percentage of patients benefit from immunotherapy?
- 6 What research has been done on ovarian cancer?
- 7 What is Clinical Cancer Research?
- 8 What is National Cancer Research Center?
What are some recent breakthroughs in cancer research?
Below are some of the more recent breakthrough agents grouped by category:
- Monoclonal antibodies, such as Trodelvy for metastatic triple-negative breast cancer.
- Oncolytic virus therapy, including Imlygic for inoperable melanoma.
- CAR T-cell therapy, such as CD22 for acute lymphoblastic leukemia relapse.
What innovations are helping the fight against lung cancer?
Technologies and innovations like CRISPR, artificial intelligence, telehealth, the Infinium Assay, cryo-electron microscopy, and robotic surgery are helping accelerate progress against cancer.
Is immunotherapy a breakthrough?
Immunotherapy has opened a new era in cancer treatment. Drugs represented by immune checkpoint inhibitors have led to important breakthroughs in the treatment of various solid tumors, greatly improving the survival rate of cancer patients.
When was the first cancer treatment made?
The discovery of X-rays and radiation by Becquerel and Rontgen in the late 19th century was the first step towards radiation treatment. Marie Curie’s work greatly contributed to the development of radiotherapy. The first cancer case cured exclusively by radiation occurred in 1898.
How has technology helped cancer research?
Advancements in technology have lessened much of that danger and made radiation into a safer, more effective form of treatment. Linear accelerators are the treatment machines used to deliver radiation to a cancer patient’s body and organs after an oncologist prescribes the appropriate dosage.
What research is currently being done on lung cancer?
Immunotherapy. Immunotherapies work with the body’s immune system to help fight cancer. They are a major focus in lung cancer treatment research today. Clinical trials are ongoing to look at new combinations of immunotherapies with or without chemotherapy to treat lung cancer.
What percentage of patients benefit from immunotherapy?
ICIs can shrink tumours and improve survival rates, even for patients for whom other cancer therapies have failed. Only 20-40\% of patients respond to immunotherapy1 and, because these drugs can activate a broad range of immune cells, they can sometimes trigger severe auto-immune reactions.
What research has been done on ovarian cancer?
Bevacizumab (Avastin) is the targeted therapy that has been studied best in ovarian cancer, but other similar drugs, like pembrolizumab, are being looked at, as well. Catumaxomab is a drug being studied specifically for people with malignant ascites (fluid buildup in the abdomen [belly] caused by cancer cells).
What is cancer breakthrough?
A bold experiment to kill a vicious form of brain cancer has been granted breakthrough status by the Food and Drug Administration. Results in the earliest stage of testing have been so remarkable, the FDA wants to fast track the treatment to speed it to market. The therapy uses the polio virus to attack glioblastoma .
What is Clinical Cancer Research?
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics.
What is National Cancer Research Center?
The Center for Cancer Research (CCR) is the basic and clinical intramural research program of the National Cancer Institute (NCI). CCR is a distinctive community of scientists and clinicians who integrate basic research discovery with the development of novel interventions against cancer and HIV/AIDS.